In our study, we identified a new blood-based model combining H3.1 containing cf-nucleosomes, IGBP-1 and MMP-9 as biomarkers to diagnose SSc-ILD in a SSc cohort. The gene discussed is IGBP1; the disease is interstitial lung disease.